Venlafaxine News and Research

RSS
Venlafaxine is an antidepressant drug that is being evaluated for the treatment of hot flashes in women who have breast cancer.
Antidepressant use during pregnancy could increase risk of birth defects in baby, study reveals

Antidepressant use during pregnancy could increase risk of birth defects in baby, study reveals

Personal fish calculator reveals safety of seafood

Personal fish calculator reveals safety of seafood

Most antidepressants are ineffective at treating children and teens, study shows

Most antidepressants are ineffective at treating children and teens, study shows

Nutritional supplements can enhance effectiveness of antidepressants

Nutritional supplements can enhance effectiveness of antidepressants

Multicenter trial compares popular treatments for menopause-related vaginal symptoms

Multicenter trial compares popular treatments for menopause-related vaginal symptoms

Two-drug combination relieves depression in older adults

Two-drug combination relieves depression in older adults

NAMS panel provides recommendations to help women manage menopause-associated vasomotor symptoms

NAMS panel provides recommendations to help women manage menopause-associated vasomotor symptoms

Johns Hopkins researchers develop new strategies to treat depression in children, adolescents

Johns Hopkins researchers develop new strategies to treat depression in children, adolescents

Unmet medication need in neuropathic pain

Unmet medication need in neuropathic pain

Estrogen therapy and venlafaxine treatment effective for hot flashes, night sweats

Estrogen therapy and venlafaxine treatment effective for hot flashes, night sweats

IQWiG completes first health economic evaluation

IQWiG completes first health economic evaluation

Janssen receives positive opinion from EMA CHMP for ZYTIGA to treat mCRPC

Janssen receives positive opinion from EMA CHMP for ZYTIGA to treat mCRPC

Newer antidepressant decreases depression in Parkinson's patients without worsening motor problems

Newer antidepressant decreases depression in Parkinson's patients without worsening motor problems

Switching or adding antidepressants does not exacerbate side effects

Switching or adding antidepressants does not exacerbate side effects

New generation antidepressants may increase risk of adverse outcomes in elderly

New generation antidepressants may increase risk of adverse outcomes in elderly

New antidepressant prescription linked to increased risk of falls in nursing home residents

New antidepressant prescription linked to increased risk of falls in nursing home residents

Dr. Reddy’s launches generic ARICEPT, EFFEXOR XR and FEMARA in the US

Dr. Reddy’s launches generic ARICEPT, EFFEXOR XR and FEMARA in the US

FDA approves Mylan's ANDA for Venlafaxine HCl ER Capsules to treat depressive, anxiety disorder

FDA approves Mylan's ANDA for Venlafaxine HCl ER Capsules to treat depressive, anxiety disorder

Otsuka Pharmaceutical reports OPC-34712 Phase 2 trial results in major depressive disorder

Otsuka Pharmaceutical reports OPC-34712 Phase 2 trial results in major depressive disorder

Study: Dual medications do not hasten recovery from depression

Study: Dual medications do not hasten recovery from depression